Nasdaq:US$13.81 (+0.07) | HKEX:HK$21.95 (-0.15) | AIM:£2.27 (-0.06)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Targeting MET in preclinical models to support the clinical development of AZD6094/HMPL-504 (savolitinib) in NSCLC